EPC066 | Depressive symptoms and health services utilization in the HIV-Hepatitis C co-infected population in Canada | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPB072 | Depressive symptoms among women by gender identity and HIV status participating in three multisite cohorts in the United States | E-poster | Mental health (including depression and psychiatric manifestations) and HIV |
EPB259 | Depression in People Living with Human Immunodeficiency Virus During the Coronavirus Disease 2019 Pandemic in 4 African Countries | E-poster | Impact of COVID-19 on HIV care |
EPD418 | Depression as a mediator between Intimate Partner Violence (IPV) and CD4 cell count among men who have sex with men (MSM) living with HIV in China | E-poster | Violence and conflict: Political, social, structural, interpersonal and family-based |
PESUA15 | Depot-medroxyprogeterone acetate use alters immune modulation function of cortisol and thyroid hormones | Poster exhibition | Mucosal immunity |
EPE347 | Demonstrating DHIS2 tracker success in large scale longitudinal client level service data and referrals for AGYW in DREAMS service delivery | E-poster | Innovative uses of data to strengthen systems and programmes |
EPE007 | Delivery of HIV self-testing and pre-exposure prophylaxis through private retail pharmacies in Kenya: a mixed methods evaluation | E-poster | Implementation science of scaling up prevention (including PrEP) |
PESAD22 | 'Delivery of clinical HIV prevention care and treatment services for Key Populations through safe spaces in Harare' | Poster exhibition | Young key populations |
EPE324 | Delivering 'Game Changer' combination HIV prevention interventions for Adolescent Girls and Young Women (AGYW) to promote epidemic control in South Africa | E-poster | Social protection: New evidence and programmatic lessons |
EPE427 | Delivering COVID19 vaccine to people living with HIV through an AIDS service organization partnership | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |